Format

Send to

Choose Destination
Am J Clin Pathol. 2009 Dec;132(6):899-905. doi: 10.1309/AJCPW37QGECDYCDO.

Tissue microarray for routine analysis of breast biomarkers in the clinical laboratory.

Author information

1
Department of Pathology and Laboratory Medicine, British Columbia Cancer Agency, Vancouver, Canada.

Abstract

Tissue microarray analysis (TMA) allows multiple analyses on multiple patients on sections from a single paraffin block. Although it is widely used in research and in quality assurance settings, there are few references to its use in clinical practice. This study evaluated TMA assessment of breast biomarkers using immunohistochemical analysis in a clinical histopathology laboratory. Performance parameters, interobserver variability, and concordance between TMA and whole section results were assessed. The arrays had few lost or noninformative cores. A loss of stain intensity occurred in the arrays compared with the whole sections with some but not all antibodies, highlighting the need to validate the staining protocol for each antibody used on TMA sections. With recommended guidelines for specimen selection and reporting, TMA was found to be an economical replacement for whole section analysis for breast biomarkers.

PMID:
19926582
DOI:
10.1309/AJCPW37QGECDYCDO
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center